Sandoz is a global leader in generic pharmaceuticals and biosimilars.
Our purpose is pioneering novel approaches to help people around the world access high-quality medicine.
At Sandoz our work is focused on improving access to medicines, access to medical information and access to medical capacity building. From its roots in 19th century Basel, the Sandoz brand has been transformed into a global leader in generic pharmaceuticals and biosimilars.
Today, we offer approximately 1,000 molecules covering a broad range of therapeutic areas. In 2020, our products reached approximately 500 million patients.